• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CLSD

CLSD

Clearside Biomedical, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.41

+0.00 (+0.00%)

Company Profile

CEO

George Lasezkay

IPO Date

2016-06-02

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.41

Prev. Close

$0.41

Day Low

$0.41

Day High

$0.41

52W Low

$0.31

52W High

$17.10

Market Cap

$0.00B

Volume

2.05M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

27.0%

Avg Negative

5.2%

Avg Neutral

67.8%

News Feed

Clearside Biomedical to Present at the Ophthalmology Futures European 2021 Virtual Retina Forum

GlobeNewsWire·8/23/2021·↑ positive

Arctic Vision Announces Expansion of License Territory for Suprachoroidal Space Injection Therapy ARVN001 to Include ASEAN Countries and India

PRNewsWire·8/15/2021·↑ positive

Clearside Biomedical, Inc. (CLSD) CEO George Lasezkay on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/10/2021·↓ negative

Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Tops Revenue Estimates

Zacks Investment Research·8/10/2021·↑ positive

Clearside Biomedical: Q2 Earnings Insights

Benzinga·8/10/2021·↑ positive

Clearside's Value Proposition Is Far From Clear

Seeking Alpha·8/7/2021·↓ negative

Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021

GlobeNewsWire·8/4/2021·↑ positive

Will Clearside Biomedical, Inc. (CLSD) Report Negative Earnings Next Week? What You Should Know

Zacks Investment Research·8/3/2021·↑ positive

Which Penny Stocks Are Investors Buying Right Now? Check These 7 Out

PennyStocks·7/5/2021·↓ negative

Why Clearside Biomedical Stock Surged Today

The Motley Fool·6/17/2021·↑ positive